MedTrace Logo

The Early History of Universal Screening for Metabolic Disorders

NCT00309400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2014-08-20

No results posted yet for this study

Summary

We are doing this study to learn more about the early history of universal screening for metabolic disorders such as PKU and galactosemia. In particular, we are interested in learning from our past experience to inform our current plans to expand universal newborn screening. Following standard historical research methodology, we will begin with a review of the historical scholarship on PKU and galactosemia, including more general works on mental retardation, genetics, public health screening, and metabolic disorders. We will also obtain scientific publications and archival sources on the early screening and treatment of these disorders. Lastly, we will conduct oral history interviews with key participants in teh early screening and treatment of PKU and galactosemia.

Conditions

Sponsors & Collaborators

  • HRSA/Maternal and Child Health Bureau

    collaborator FED

  • University of Miami

    lead OTHER

Principal Investigators

  • Jeffrey P Brosco, MD, PhD · University of Miami

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-01-31
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00309400 on ClinicalTrials.gov